REGENERON PHARMACEUTICALS, INC. Cash & Short-Term Investments 2007-2026 | REGN
Beta
What is REGENERON PHARMACEUTICALS, INC.'s current cash & short-term investments?
REGENERON PHARMACEUTICALS, INC. (REGN) annual cash & short-term investments for 2025 was $8.61B, a 4.52% decline from 2024. REGENERON PHARMACEUTICALS, INC. cash & short-term investments for the quarter ending March 31, 2026 was $8.75B.
What was REGENERON PHARMACEUTICALS, INC.'s cash & short-term investments in 2024?
REGENERON PHARMACEUTICALS, INC. annual cash & short-term investments for 2024 was $9.01B, a 16.90% decline from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s cash & short-term investments in 2023?
REGENERON PHARMACEUTICALS, INC. annual cash & short-term investments for 2023 was $10.84B, a 39.83% increase from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year cash & short-term investments CAGR?
REGENERON PHARMACEUTICALS, INC. cash & short-term investments grew at a compound annual growth rate (CAGR) of 19.04% from FY2020 to FY2025, going from $3.60B to $8.61B over 5 years.
Cash & Short-Term Investments History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Declining
CAGR+19.0%
FY2020
$3.60B
→
FY2025
$8.61B
07080910111213141516171819202122232425
5 years selected
Cash & Short-Term Investments History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $8.61B | -4.5% | 10-K |
| FY2024 | $9.01B | -16.9% | 10-K |
| FY2023 | $10.84B | +39.8% | 10-K |
| FY2022 | $7.76B | +35.9% | 10-K |
| FY2021 | $5.71B | +58.5% | 10-K |
| FY2020 | $3.60B | +11.6% | 10-K |
| FY2019 | $3.23B | +14.3% | 10-K |
| FY2018 | $2.82B | +100.2% | 10-K |
| FY2017 | $1.41B | +35.7% | 10-K |
| FY2016 | $1.04B | -0.6% | 10-K |
| FY2015 | $1.05B | +16.1% | 10-K |
| FY2014 | $900.5M | +29.8% | 10-K |
| FY2013 | $694.0M | +125.3% | 10-K |
| FY2012 | $308.1M | -41.5% | 10-K |
| FY2011 | $526.9M | +111.3% | 10-K |
| FY2010 | $249.4M | -26.9% | 10-K |
| FY2009 | $341.3M | +37.7% | 10-K |
| FY2008 | $247.8M | -50.3% | 10-K |
| FY2007 | $498.9M | - | 10-K |
Company: REGENERON PHARMACEUTICALS, INC.Ticker: REGNSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →